Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: A case-control study

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Park, Jung Min ^a   Choi, Jin Eun ^a   Chae, Myung Hwa ^a   Lee, Won Kee ^a   Cha, Sung Ick ^a   Son, Ji Woong ^b   Kim, Chang Ho ^a   Kam, Sin ^a   Kang, Young Mo ^a   JunG, Tae Hoon ^a   Park, Jae Yong ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Konyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYSTEINE; THREONINE;

3' UNTRANSLATED REGION; AGE DISTRIBUTION; ARTICLE; CANCER PATIENT; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; INDIVIDUALITY; KOREA; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RESTRICTION MAPPING; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK; SEQUENCE ANALYSIS, DNA; SEX FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 33646891066     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-70     Document Type: Article

References (35)

1. Shields PG, Harris CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000, 18(11):2309-2315.
2. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE: Cyclooxygenases in biology and disease. FASEB J 1998, 12(12):1063-1073.
3. Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000, 69:145-182.
4. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN: Up-regulation of cyclooxygenose 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107(4):1183-1188.
5. Parrett ML, Harris RE, Joarder FS, Ross MS, Clausen KP, Robertson FM: Cyclooxygenase-2 expression in human breast cancer. Int J Oncol 1997, 10:503-507.
6. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A: Expression of Cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998, 58(22):4997-5001.
7. Sheng H, Shao J, Washington MK, DuBois RN: Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001, 276(21):18075-18081.
8. Tsujii M, Kawano S, Tsujii S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer. Cell 1998, 93(5):705-716.
9. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 1995, 83(3):493-501.
10. Goodwin JS, Ceuppens J: Regulation of immune response by prostaglandins. J Clin Immunol 1983, 3(4):295-315.
11. Harris RE, Beebe-Donk J, Schuller HM: Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep 2002, 9(4):693-695.
12. Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig KL, Shore RE: Aspirin and lung cancer in women. Br J Cancer 2002, 87(1):49-53.
13. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T: Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998, 58(17):3761-3764.
14. Ermert L, Dierkes C, Ermert M: Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. Clin Cancer Res 2003, 9(5):1604-1610.
15. Spitz MR, Wei Q, Dong Q, Amos Cl, Wu Z: Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomark Prev 2003, 12(8):689-698.
16. Feyler A, Voho A, Bouchardy C, Kuokkanen K, Dayer P, Hirvonen A, Benhamou S: Myeloperoxidase -463 G → A polymorphism and lung cancer risk. Cancer Epidemiol Biomark Prev 2002, 11(12):1550-1554.
17. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ: Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thomb Vasc Biol 2002, 22(10):1631-1636.
18. Campa D, Zienolddiny S, Maggini V, Skaug V, Haugen A, Canzian F: Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 2004, 25(2):229-235.
19. Kang S, Kim YB, Kim MH, Yoon KS, Kim JW, Park NH, Song YS, Kang D, Yoo KY, Kang SB, Lee HP: Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. Cancer Lett 2005, 217(1):11-16.
20. Koh WP, Yuan JM, van de Berg D, Lee HP, Yu MC: Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br J Cancer 2004, 90(9):1760-1764.
21. Cui JG, Salehi-Rad S, Rogaeva E, Lukiw WJ: Characterization of a cyclooxygenose-2 -765G→C promoter polymorphism in human neural cells. Neuroreport 2005, 16(6):575-579.
22. Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Cho YL, Jung TH, Park JY: DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2004, 26(2):403-409.
23. Lee GY, Jang JS, Lee SY, Jeon HS, Kim KM, Choi JE, Park JM, Chae MH, Lee WK, Kam S, Kim IS, Lee JT, Jung TH, Park JY: XPC polymorphisms and lung cancer risk. Int J Cancer 2005, 115(5):807-813.
24. Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY, Son JW, Kim CH, Lee WK, Kam S, Park RW, Park TI, Kang YM, Kim IS, Jung TH, Park JY: Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomark Prev 2005, 14(3):571-575.
25. Lee CT, Kang KH, Koh Y, Chang J, Jung HS, Park SK, Yoo KY, Song JS: Characteristics of lung cancer in Korea, 1997. Lung Cancer 2000, 30(1):15-22.
26. Hu Z, Miao X, Ma H, Wang X, Tan W, Wei Q, et al.: A common polymorphism in the 3′UTR of cyclooxygenase 2 /prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 2005, 48:11-17.
27. Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC: The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomark Prey 2000, 9(10):1037-1042.
28. Li G, Wang LE, Chamberlain RM, Amos CI, Spitz MR, Wei Q: p73 G4C14-to-A4T14 polymorphism and risk of primary lung cancer. Cancer Res 2004, 64(19):6836-6866.
29. Shaw G, Kamen R: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46(5):659-667.
30. Gou Q, Liu CH, Ben-Av P, Hla T: Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem Biophys Res Commun 1998, 242(3):508-512.
31. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM: Post-transcriptional control of cyclooxygenase-2 gene expression. J Biol Chem 2000, 275(16):11750-11757.
32. Cok SJ, Morrison AR: The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translation efficiency. J Biol Chem 2001, 276(25):23179-23185.
33. Cipollone F, Toniato E, Martinotti S, Fazia M, Iezzi A, Cuccurullo C, Pini B, Ursi S, Vitullo G, Averna M, Arca M, Montali A, Campagna F, Ucchino S, Spigonardo F, Taddei S, Virdis A, Ciabattoni G, Notarbartolo A, Cuccurullo F, Mezzetti A: A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004, 291(18):2221-2228.
34. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000, 405(6788):847-856.
35. Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC: SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomark Prev 2004, 13(5):681-687.